In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 5th, 2008 | 18 | Yes |
Popular Name: Imiquimod Imiquimod
Find On: PubMed — Wikipedia — Google
CAS Numbers: 99011-02-6 , 99011-78-6 , [99011-02-6]
1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
1-(2-methylpropyl)-4-imidazo[4,5-c]quinolinamine
1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ylamine
1-isobutylimidazo[4,5-c]quinolin-4-amine
1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-
1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline
99011-02-6; Aldara (TN); D02500; Imiquimod (JAN/USAN/INN); Zyclara (TN)
CPD000469189; IMIQUIMOD ACETATE; Imiquimod; SAM001246660
CPD000469189; IMIQUIMOD ACETATE; SAM001246660
Imiquimod / 1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]Q
Imiquimod / 1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.66 | 6.8 | -10.57 | 2 | 4 | 0 | 57 | 240.31 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.47e-01 g/l | DrugBank-approved |
MP | 294 | TCI |
Purity | 97% | Fluorochem |
biological_use | Cytostatic | IBScreen Bioactives |
Patent Database Links | EP1495758; EP1529781; EP1685843; EP1743896; EP1767216; EP1849797; EP1872775; EP1889609; EP1891953; EP1894941; EP1958613; EP1958956; US2005004144; US2005085500; US2005197299; US2005266024; US2007184059; US2007184096; US2007189977; US2007196323; US200719632 | ChEBI |
UniProt Database Links | IGFL_MOUSE | ChEBI |
Target | Immunology & Inflammation related | Selleck Chemicals |
Therapy | immunomodulator | SMDC Pharmakon |
biological_use | Immunostimulant | IBScreen Bioactives IBScreen Bioactives |
mechanism | Interferon inducer | IBScreen Bioactives IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP00581I; 1 acetic acid | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
Reactome Database Links | REACT_24948; REACT_24953; REACT_24964; REACT_24966; REACT_25001; REACT_25002; REACT_25011; REACT_25086; REACT_25090; REACT_25150; REACT_25184; REACT_25251; REACT_25312; REACT_25392; REACT_9012 | ChEBI |
mechanism | Reported cell proliferation inducer | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP00581I; SALT: 1 acetic acid | NIH Clinical Collection via PubChem |
Purity | USP 24 | APIChem |
biological_use | Virucide | IBScreen Bioactives |
Indications | warts | KeyOrganics Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TLR7-1-E | Toll-like Receptor 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2120 | 0.44 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TLR7_HUMAN | Q9NYK1 | Toll-like Receptor 7, Human | 2120 | 0.44 | Functional ≤ 10μM |
Description | Species |
---|---|
MyD88 dependent cascade initiated on endosome | |
MyD88-dependent cascade initiated on endosome membrane | |
NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 stimulation | |
TLR7 cascade | |
Toll Like Receptor 7/8 (TLR7/8) Cascade | |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | |
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
Description | Species |
---|---|
MyD88 dependent cascade initiated on endosome | |
Toll Like Receptor 7/8 (TLR7/8) Cascade | |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | |
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | |
Trafficking and processing of endosomal TLR |
No pre-computed analogs available. Try a structural similarity search.